Second Heart Assist yesterday filed an SEC Form D revealing that it sold more than $4 million in equity.
The filing, which totaled approximately $4.1 million, was classified as a new notice, with the first sale made Dec. 31, 2016.
Second Heart Assist labeled both the total offering amount and the total remaining to be sold as “indefinite.” The company listed 76 total investors, along with four non-accredited investors.
The Salt Lake City-based company did not disclose how it would use the funds, but it is developing the Second Heart Assist device for treating heart failure.
The Second Heart Assist device is a catheter-based, minimally invasive circulatory support platform designed to provide temporary or chronic support designed to treat patients with acute decompensated heart failure and provide support to those undergoing percutaneous coronary intervention.
Second Heart Assist plans to pursue another application for the device in which it will be a wirelessly powered circulatory assist pump designed to provide chronic circulatory support for heart failure patients.